April 2026—It’s hard to mount an argument against the Great Plains. Nor is there much reason to. But drive across eastern Colorado, Nebraska, Kansas, or the Dakotas, and it is a bona fide thrill to arrive in Wyoming’s northwest corner and see the Grand Tetons rising up in spectacular fashion.
ASCO to shine light on multimodal AI models:
Plus, melanoma diagnostics and gastroesophageal cancer targets
April 2026—Artificial intelligence, circulating tumor DNA, trial data: ASCO 2026 next month in Chicago will feature platforms, technologies, and therapeutic approaches once considered future concepts in cancer diagnosis and care. What comes now is less flashy than a breakthrough advance perhaps, but no less significant. As Janice Lu, MD, PhD, puts it, “The real work now is disciplined clinical translation: validation, collaboration, and implementation, in ways that truly improve patient care.”
April 2026—Revisions and additions to the CAP transfusion medicine accreditation checklist released last year were made to safeguard patients, donors, and the blood bank inventory.
SPONSORED ROUNDTABLES
April 2026—Thermo Fisher Scientific’s SwiftArrayStudio microarray analyzer was developed in response to customer needs for simpler workflows, more consistent turnaround times, and lower operational burden in genomics labs.
CAP TODAY RECOMMENDS
February 2026—Prepared with expert insight from Anil Parwani, MD, PhD; Scott Hammond; and Melinda Schumacher, MD, Grundium’s white paper describes, from a pathologist’s perspective, how compact WSI systems can shorten consult turnaround times and reduce variability, improve access to subspecialty review without adding travel or courier burden, enhance community pathologists’ professional satisfaction and confidence, support scalable, secure, and validated workflows and lay the foundation for AI and advanced analytics as digital adoption grows. Download the white paper here.
April 2026—Pathologists are physicians who play a crucial role in patient care, providing accurate diagnoses and guiding treatment decisions. Despite often working behind the scenes, pathologists are essential to modern medicine, contributing to advancements in precision medicine and molecular diagnostics.
Interactive Product Guides
Use our comprehensive guides to view and compare instruments and software systems feature by feature.
FEATURED GUIDE: Billing
April 2026—Laboratory and pathology billing face challenges from reimbursement threats, downcoding, denials, and prior authorizations.
PRODUCT GUIDE ROUNDTABLES
MARKETPLACE
October 2019—The Project Santa Fe Foundation, which developed the concept of Clinical Lab 2.0, announced that it has filed for nonprofit 501c status and expanded its board of directors. New members of the board include health care leaders from Seattle Children’s Hospital, Intermountain Healthcare, University of Vermont, Mayo Clinic, and NorthShore University HealthSystem. “It is by design that PSFF did not trademark Clinical Lab 2.0, as we strongly believe that Clinical Lab 2.0 belongs to the health care industry, not to a single entity, and fundamentally believe that Clinical Lab 2.0 has no borders,” Khosrow Shotorbani, MBA, MT(ASCP), president and executive director of the Project Santa Fe Foundation, said in a press release. “The transition to value-based, Clinical Lab 2.0 standards will require cross-industry collaboration. We are honored to have these highly respected industry leaders join the global movement.” Project Santa Fe is a nonprofit organization founded through a collaboration of the Henry Ford Health System, Northwell Health, Geisinger Health System, and TriCore Reference Laboratories.